week 2 Flashcards
what is affected in RA?
synovium
what mediates RA?
HLA-DR4
describe RA
inflammatory arthritis, symmetirial, F>M. any age, 1% prevalence.
smoking and genetics lead to worse outcome.
presence of auto-antibodies gives worse prognosis.
commonly affected sites in RA
c1/C2, hand joints, wrist, elbow, shoulders, TMJ, knees, hips, ankle, feet. (synovium lined)
what is the hallmark of RA
synovitis. (spongey on examination)
Get inflammatory “pannus” with inflammatory cascade (osteoclasts erode, B cells give Rheumatoid factor, mast cells cause inflammation, and neutrophils….)
early RA and therapeutic window
<2 years, first 3 months best therapeutic window.
PC of RA
- early morning stiffness greater than 30min
- more than one area
- hand joint
- symmetrical
- positive ‘squeeze’ test of MCP/MTP
diagnosis of RA
Hx, Examination,
bloods: FBC (check for anaemia of chronic disease, inc platelets ) CRP + ESR/PV [inflammatory markers]
radiology [for staging ]
autoantibodies [may be negative]
what is tenosynovitis
caused by RA. tendon sheath inflammation. causes carpal tunnel PIP, MCP, MTP joint inflammation.
autoantibodies to check for in RA
rheumatoid factor and anti-CPP (better)
imaging for RA
x-ray hand/feet. US. MRI (gold standard.)
how do you assess RA
DAS-28. <2.6= disease remission and >5.1 is high activity.
management of RA
rheumatologist, drugs, target good DAS28 score, steroid/NSAID’s, patient education.
High high with NSAID + steroids (not tot long as side effects - use as bridging therapy until DMARD’s kick in) initially then drop down once in remission (gain control the reduced drugs)
DMARDs in RA
Methotrexate
sulphasalazine
hydroxycholoroquine
(biologic therapy ).
also gold therapy, penicillamine, azothiaprine.
what do you need to check if giving biological therapy (anti-TNF)
bacterial and TB reactivation
how can steroids be administered in RA
oral, IM, IA.
how is MTX administered and what needs co-prescribed with Methotexate.
weekly injection.
folic acid.
risks of methotrexate
pneumonitis, LFT’s, teratogenic, reduced FBC.
what needs considered when prescribing biological therapy for RA patients
DAS28 score, TB/HIV/Hep B status, methotrexate co-prescibed. no live-attenuate vaccine (EG: yellow fever)
what are the signs of advanced RA
joint damage and deformity. atlanto-axial sublaxation
things to consider in paint with RA on medication
pregnancy, accelerate CVS risk, immunisations, stop smoking, keep DAS28 score good
what is the commonest arthritis
OA (osteoarthritis)
What happens in OA
progressive degenerative disease, thinning of cartilage with loss of joint space and bony spurs formation
pathogenesis of OA
loss of matrix of cartilage, cytokine release (Il-1, TNF, mixed metalloproteinases and prostaglandins).
fibrillated cartilage surface, bone formed not cartilage.
Pc of OA
gradual onset, mechanical pain, crepitius, stiffness, deformity/swellings of joints. reduced function and mobility. effusions and soft tissue swelling present.
common sites of OA
hip, knee, neck, big toes, thumb/fingers. (weight bearing/mechanical overuse/stress joints)
what are hebardons nodes
occur in OA, DIP bony enlagements
what are bouchards nodes
occur in OA, PIP bony enlargements.
what is a Baker’s cyst
synovial bursa in popliteal fossa.
risk factors for OA
age, female, FHx, occupation, obesity, previous joint injury/abnormalities. underlying RA, gout, acromegaly
diagnosis of OA
Hx + Examination.
bloods - inflammatory markers raised usually.
X-rays (joint space narrowing, bony cyst, osteophytes, subchondrial sclerosis)
treatment of OA
non-pharam = educate, physio, weight loss, walking aid, footwear
pharma= analgesia, NSAID’s, pain modulators (gabapectin, amitriptyline), IA steroid (only short-term relief )
surgery = arthroscope washout, soft tissue trimming, joint replacement.
what does IA stand for
intraarticular
crystal arthropathies; name the two and their causing crystals
gout (monosodium urate) and psuedogout (calcium pyrophosphate dihydride/CPPD)
what is Gout
inflammartoy arthritis associated with monosodium urate crystal deposition. occurs in older men mostly. (1% population)
Gout pathogeneisis
PURINES from diet and DNA/ RNA sources (due to cell breakdown = cancer, weight loss, sepsis, psoriasis exacerbate) → hypoxanthine → xanthine → plasma Urate→ urine uric acid (water soluble but if dehydrated causes Gout)
what is hyperuracaemia
high uric acid in blood (>7mg/dL). present in 18% population. inc risk of Gout with higher uric acid levels in blood.
diagnosis of Gout
based on radiological finding, not hyperuracemia alone; [acute changes in uric acid levels often lead to Gout.]
however, 25% in acute attack have normal uric acid levels , optimum is 2 weeks after attack.
clinical presentation of Gout
rapid onset, big toe, sever pain, red/hot joint, up to 2 weeks.
DD of Gout
Gout, trauma, septic arthritis, seronegative arthritis (EG:psoriatic)
chronic polyarticular gout
chronic joint inflammation, inc uric acid, recurrent acute attacks, >10years.
investigation for gout
high CRP, ESR/PV. sometimes high WCC.
Xray normal actually, chronic shows erosions, joint destruction, overhanging osteophytes.
Aspirate joint = gold standard (differentiate between septic arthritis)
management of gout
acute= Nsaid’s or colchicine or corticostreroids (oral, IM, IA); analgesia (opiates and paracetamol).
chronic= lifesytle change (reduce red meat, seafood, beans and alcohol.). lose weight, inc fluids (non fructose - no fizzy drinks).
GIVE ALLOPURINOL/FEBUXOSTAT after acute attack stops and at low dose then step up checking uric acid levels. long term → reduce acute attacks.
what is pseudogout
occurs in elderly, calcium deposition in cartilage. related to OA. Alcohol and diet has no relevance
where does pseudogout commonly affect
knees, wrists, ankles.
diagnosis of pseudogout
joint aspirate shows rhomboid shaped crystals with weak +ive birefringence.
what is pseudogout associated with?
hyperparathryoidism, haemochromatosis, haemosidenosis, trauma, amyloidosis, gout, hypothryroidism.
treatment of pseudogout
nsaid’s, colchicine, steroid, rehydrate.
control other conditions. (gout therapy doesn’t work for psuedogout).
stop diuretics
name a rare for of psuedogout caused by hydroxyapatite crystals.
milwalkee shoulder - aggressive acute and rapid deteroration, occurs in females 50-60 years old.
alizain stain shows red clumps. (not seen in tayside)
CTD overview
often autoimmune disease (AID).
includes SLE, sjogre’s, polymyositis, APS, systemic sclerosis, mixed CTD.
CTD is caused by spontaneous overactivity of IS, systemic, autoimmune, every part of the body → inflammation/tissue damage.
SLE - systemic lupus erythematosus. risk factors
ethnicity (chinese/afro-americans/carribeans), female
what factors cause SLE to develop
hormones (oestrogen/HRT), envorinmental (viruses/UV light), genetics, immunology → SLE
pathogenies of SLE
antigen presenting cells → CD4 helper Tcell → Bcells (→ antibodies) + CD8 cytotoxic T cell. → cell death.
dead cells are left in the body too long in lupus and are then seen as antigen/threat triggering autoimmune attack
lupus characteristic disease pathway
inc turnover + longer to clear dead cells → immune complexes formation drives disease (inflammation of blood vessels occurs also) - type III hypersensitivity.
how does SLE causes renal disease? how is it diagnosed?
immune complexes deposited in mesangium; symptomatic and severe → necrosis and scarring (inc blood or protein in urine, seen on urinalysis.)
shows glomerular nephritis, renal biopsy if unsure.
cutanoues signs of SLE
mouth ulcers, hair thinning, butterfly/malar rash (post-UV light), discoid lupus → may scar.
chronic and acute.
Signs of SLE
renal disease, cutaneous, arthritis, serositis (pleural inflammation), neurological, haemolytic anaemia, thrombocytopenia, leukopenia
neurological signs of SLE
depression, psychosis, peripheral neuropathy.
classification of SLE
mild - joint and skin affected
moderate
severe- life-threatening = renal, ham, neuro affected
immunology of lupus
ana, ANTI-DNA. - best two
anti-Sm, Anti-Ro, Anti-RNP (lupus and others.)
symptoms of SLE
fever, fatigue, weight loss, myalgia, headache, anglarged lymph nodes, joint pain/swelling
what condition often occurs with SLE
APS - anti-phospholipid syndrome.
clots in artery/vein, causes recurrent miscarriage + PE/DVT [high D-dimer]
why are lupus patients more susceptible to infection?
low complement levels.
defective phagocytosis,
steroid/immunosuppressant drugs
investigations for lupus (Bloods only not screening )
ANA (+ive in hep C, HIV, RA, other AID’s)
Anti-double standed DNA (most associated and gives level of disease and associated with kidney disease - BEST)
anti-Ro. presence in pregnant SLE patients predicts neonatal problems (heart block)
anti-phospholipid → 3 blood tests. higher value then inc clot likelihood.
screening of lupus
multi-organ screening.
urinalysis always plus others if symptomatic (e.g.: CXR for lung problems).
flare-up of lupus causes what blood results
inc anti-DNA and reduced C4 level.
also inc PV/ESR but not CRP (never raised in SLE, in other AID’s can be raised )
what does CRP indicate
- infection
- AID’s (apart from SLE)
treatment of SLE (generally)
GENERAL: educate, regular monitoring, avoid UV light, pregnancy issues.
treatment of SLE (mild)
NSAID’s and analgesia, (anti-malaria) hydroxycholoroquine/HCQ, helps with organ protection, joint pain and skin (therefore - everyone with SLE on HCQ)
treatment of SLE (moderate)
steroid is severe (low dose if joints, high dose if kidney)
+ immunosuppressants (1st line is cyclophosphamide, methotrexate, azathioprine ). → leads to reduced IS, bone marrow suppression, potentially teratogenic.
treatment of severe SLE
immunospuressant + steroid (IV and inc dose).
+Biological therapy = anti-CD20 + anti-Blys.
may acutely need Warfarin is haematology’s bad.
what are the symptoms of CTD
arthralgia, fatigue, myalgia, reynaud’s, alopecia, mucosal ulcers, unprovoked thrombosis/ pregancy losses, sicca (dryness) symptoms.
AID’s general points
female > male often overlap, primary or secondary most is B cell mediated (gives antibodies) inc CVS risk
what is APS (anti-phospholipid syndrome)
venous or arterial thrombosis+ adverse pregnancy. can be primary or secondary. [anti-cardiolipin antibody present]